Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Oncology

The Biology of KS and Your Pathology Report

At a Glance

Kaposi sarcoma (KS) is diagnosed by finding the Human Herpesvirus 8 (HHV-8) in a tissue biopsy, often reported as LANA-1 positive. Your pathology report will note distinctive features like spindle cells and leaky blood vessels, which confirm KS and rule out other similar conditions.

Kaposi sarcoma (KS) is not a typical cancer; it is a unique growth of the cells that line your blood and lymph vessels, driven by a specific virus [1]. Understanding how this virus changes your body’s biology and how those changes appear on a pathology report is the first step in taking control of your diagnosis.

The Biology: How the Virus Takes Over

The engine behind KS is Human Herpesvirus 8 (HHV-8), also known as KSHV [1]. This virus targets lymphatic endothelial cells—the cells that form the “plumbing” of your immune system [2].

Once inside, the virus uses a specialized protein called LANA-1 (Latency-Associated Nuclear Antigen-1) [2]. Think of LANA-1 as an anchor: it keeps the virus’s DNA tethered to your own cells so it doesn’t get lost when cells divide [3]. The virus also releases “fake” signals, like viral IL-6, which trick the body into a state of constant inflammation [4][2]. This inflammation fuels the growth of abnormal, leaky blood vessels that eventually form the characteristic KS lesions [4].

Symptoms: What to Look For

KS often presents in ways that can be easily overlooked or mistaken for other conditions.

  • Cutaneous (Skin) Symptoms: Most KS begins as flat, painless, reddish-purple spots (patches). Over time, these can become raised (plaques) or form firm lumps (nodules) [5][6]. Because it affects lymphatic vessels, you may also experience severe swelling (lymphedema) in the legs, groin, or face even before lesions appear [7]. Lesions often appear on the feet or lower legs, but can even show up under a fingernail or toenail [8][9].
  • Oral (Mouth) Symptoms: Early signs often appear on the roof of the mouth (palate) or gums as purple or red patches [5]. These are sometimes dismissed as simple irritation or mouth sores [10].
  • Visceral (Internal) Symptoms: KS can hide inside the body. If it affects the lungs, it may cause a persistent cough or shortness of breath [11][12]. In the digestive tract, it can mimic inflammatory bowel disease, causing abdominal pain, weight loss, or bloody stools [13][14].

Decoding Your Pathology Report

When a doctor biopsies a lesion, a pathologist looks at the tissue under a microscope. Here are the key terms you might see:

  • LANA-1 or HHV-8 Positive: This is the most important part of the report. It means the pathologist found the virus in the cells [15]. This confirms the diagnosis of KS and rules out “look-alikes” like angiosarcoma (a more aggressive blood vessel cancer) or hemangiomas (benign growths), which will test negative for this virus [16][17].
  • Spindle Cells: These are the hallmark of KS. They are cells that have been stretched into a long, spindle-like shape by the virus [1][18].
  • Slit-like Spaces: Because the new blood vessels are malformed, they create narrow, irregular gaps instead of round tubes [1][18].
  • Extravasated Erythrocytes: This is a fancy way of saying “leaked red blood cells.” These cells escape through the slit-like spaces into the surrounding tissue, which is what gives KS its purple color [1].
  • Hyaline Globules: Small, round, pinkish clumps of protein often seen in or around the spindle cells [1].

Pathology Completeness Checklist

A high-quality pathology report should provide enough information to guide your treatment. Check your report for these four essential items:

  1. Definitive Diagnosis: Does it state “Kaposi Sarcoma”?
  2. LANA-1/HHV-8 Result: Is it explicitly mentioned as positive? [19][20]
  3. Histologic Stage: Does it categorize the lesion as a patch, plaque, or nodule? [6]
  4. Microscopic Features: Does it mention spindle cells and slit-like vascular spaces? [1]

Common questions in this guide

What does LANA-1 or HHV-8 positive mean on my biopsy report?
A positive LANA-1 or HHV-8 result confirms the diagnosis of Kaposi sarcoma. It means the pathologist found the specific virus that causes this condition in your cells, which rules out other types of skin growths or tumors.
What are spindle cells in a Kaposi sarcoma report?
Spindle cells are the hallmark feature of Kaposi sarcoma. They are cells that have been stretched into a long, spindle-like shape by the human herpesvirus 8 (HHV-8) infection.
What are the early symptoms of Kaposi sarcoma?
Early signs often include flat, painless reddish-purple spots on the skin or the roof of the mouth. You might also experience severe swelling in the legs, groin, or face even before any visible lesions appear.
Why does my report mention extravasated erythrocytes?
Extravasated erythrocytes simply means leaked red blood cells. In Kaposi sarcoma, new blood vessels are malformed and leaky, causing red blood cells to escape into the surrounding tissue and giving the lesions their purple color.
Can Kaposi sarcoma affect my internal organs?
Yes, Kaposi sarcoma can develop inside the body, most commonly in the lungs or digestive tract. Internal lesions can cause symptoms like a persistent cough, shortness of breath, abdominal pain, or bloody stools.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was LANA-1 (HHV-8) immunostaining performed on my biopsy, and were the results positive?
  2. 2.Does my pathology report show any 'aggressive' features, or does it appear to be in the 'patch' or 'plaque' stage?
  3. 3.Based on the location of the biopsy, are you concerned about internal (visceral) involvement in my lungs or digestive tract?
  4. 4.How do these pathology results differentiate my condition from other vascular tumors like angiosarcoma?
  5. 5.Can you walk me through the 'Microscopic Description' section of my report and explain what the findings mean for my treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Prognostic factors in Kaposi sarcoma, single centre experience.

    Değerli E, Oruç K, Şentürk Öztaş N, et al.

    The Australasian journal of dermatology 2024; (65(5)):444-450 doi:10.1111/ajd.14309.

    PMID: 38760927
  2. 2

    Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon.

    Nasir MW, Gao Y

    Journal of medical virology 2025; (97(11)):e70695 doi:10.1002/jmv.70695.

    PMID: 41217111
  3. 3

    Herpesvirus-induced spermidine synthesis and eIF5A hypusination for viral episomal maintenance.

    Choi UY, Lee JJ, Park A, et al.

    Cell reports 2022; (40(7)):111234 doi:10.1016/j.celrep.2022.111234.

    PMID: 35977517
  4. 4

    The Origin of Kaposi's Sarcoma and Other KSHV-Associated Sarcomas.

    Yuan Y, Ding Y

    Journal of medical virology 2025; (97(11)):e70675 doi:10.1002/jmv.70675.

    PMID: 41186061
  5. 5

    AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

    Reid E, Suneja G, Ambinder RF, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2019; (17(2)):171-189.

    PMID: 30787130
  6. 6

    Kaposi Sarcoma Updates.

    Etemad SA, Dewan AK

    Dermatologic clinics 2019; (37(4)):505-517 doi:10.1016/j.det.2019.05.008.

    PMID: 31466590
  7. 7

    Lymphedema and Kaposi sarcoma: A narrative review.

    Dauguet M, Lebbé C, Vignes S

    Journal de medecine vasculaire 2023; (48(5-6)):181-187 doi:10.1016/j.jdmv.2023.10.007.

    PMID: 38035924
  8. 8

    Kaposi Sarcoma: A Case of Mistaken Identity in an Immunocompetent Healthy Male.

    Staab E, Reyes DC, Georgesen C, Menning M

    European journal of case reports in internal medicine 2025; (12(12)):005879 doi:10.12890/2025_005879.

    PMID: 41536445
  9. 9

    Kaposi Sarcoma of the Nail Unit: A Case Report and Review of the Literature.

    Krygier J, Sass U, Meiers I, et al.

    Skin appendage disorders 2023; (9(6)):465-469 doi:10.1159/000532114.

    PMID: 38058540
  10. 10

    Kaposi Sarcoma Mimicking a Lingual Lesion in an HIV-Negative Patient: A Case Report.

    Andrade-Carmona VR, Carmona-Araiza LG, Soria-Cespedes D, et al.

    Cureus 2024; (16(3)):e57131 doi:10.7759/cureus.57131.

    PMID: 38681393
  11. 11

    Cardiac Kaposi Sarcoma Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome: A Case Report.

    Dagher AB, Lee J, Cunningham HE, et al.

    Cureus 2025; (17(1)):e76972 doi:10.7759/cureus.76972.

    PMID: 39912008
  12. 12

    Pulmonary Kaposi's Sarcoma - Initial Presentation of HIV Infection

    Komitova R, Chudomirova K, Abadjieva T

    Folia medica 2019; (61(4)):643-649 doi:10.3897/folmed.61.e47945.

    PMID: 32337885
  13. 13

    Cyclosporine-Induced Kaposi Sarcoma in a Patient With Ulcerative Colitis.

    Clarke LM, Chawla K, Tabbara N, et al.

    ACG case reports journal 2021; (8(5)):e00600 doi:10.14309/crj.0000000000000600.

    PMID: 34079842
  14. 14

    Colon ulcers and HIV: an image to remember.

    Gómez Perosanz R, Quiñones Calvo M

    Revista espanola de enfermedades digestivas 2025; (117(10)):609-610 doi:10.17235/reed.2025.11078/2025.

    PMID: 39968649
  15. 15

    Variability of HHV8 LNA-1 Immunohistochemical Staining Across the 3 Histologic Stages of HIV-Associated Mucocutaneous Kaposi Sarcoma: Is There a Relationship to Patients' CD4 Counts?

    Mohanlal RD, Pather S

    The American Journal of dermatopathology 2015; (37(7)):530-4 doi:10.1097/DAD.0000000000000363.

    PMID: 26091511
  16. 16

    A Series of Patients with Kaposi Sarcoma (Mediterranean/Classical Type): Case Presentations and Short Update on Pathogenesis and Treatment.

    Temelkova I, Tronnier M, Terziev I, et al.

    Open access Macedonian journal of medical sciences 2018; (6(9)):1688-1693 doi:10.3889/oamjms.2018.354.

    PMID: 30337990
  17. 17

    Management of Vascular Sarcoma.

    Subramaniam A, Giani C, Napolitano A, et al.

    Surgical oncology clinics of North America 2022; (31(3)):485-510 doi:10.1016/j.soc.2022.03.014.

    PMID: 35715146
  18. 18

    KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation.

    Kieffer-Kwon P, Happel C, Uldrick TS, et al.

    PloS one 2015; (10(8)):e0135560 doi:10.1371/journal.pone.0135560.

    PMID: 26263384
  19. 19

    Laser Therapy Approaches in the Treatment of Kaposi's Sarcoma: A Comprehensive Review of Dermatologic Options.

    Battilotti C, Cassalia F, Svara F, et al.

    Dermatology practical & conceptual 2025; (15(3)) doi:10.5826/dpc.1503a5332.

    PMID: 40790410
  20. 20

    A retrospective review of patients with Kaposi's sarcoma in Botswana.

    Slaught C, Williams V, Grover S, et al.

    International journal of dermatology 2019; (58(6)):707-712 doi:10.1111/ijd.14305.

    PMID: 30460985

This page explains Kaposi sarcoma biology and pathology terminology for educational purposes. Your pathologist and oncologist are the best sources for interpreting your specific biopsy results and guiding your care.

Get notified when new evidence is published on Kaposi sarcoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.